HAVE YOU TESTED POSITIVE FOR COVID-19? YOU MAY QUALIFY FOR OUR REGENCOV COVID-19 MONOCLONAL ANTIBODY TREATMENT. PLEASE SPREAD THE WORD TO FAMILY AND FRIENDS! CONTACT US AT 305.603.7650
WHAT IS REGENCOV?
With the Covid-19 Pandemic in full swing the question commonly arises. “What do I do if I get Covid?”. Well now, Medi-Station Urgent Care Clinic provides patients with the new REGENCOV monoclonal antibodies IV infusion. We are able to conveniently and safely administer this treatment at our clinic or at your home. Call our clinic now to book your appointment 305.603.7650
WHAT ARE MONOCLONAL ANTIBODIES?
Monoclonal antibodies are antibodies created in a lab to specifically “neutralize ” the COVID-19 virus. It has been shown to decrease symptoms and decrease the progression of illness in those patients with mild to moderate symptoms. We’ve seen best results and administer it to those who are at higher risk of deterioration most often.
HOW DO MONOCLONAL ANTIBODY TREATMENT WORK AT MEDISTATION URGENT CARE CLINIC?
Medi-Station Urgent Care is bringing this therapy to our local community for qualifying patients. This includes all of Miami-Dade county.
The FDA has authorized the use of this medication under an Emergency Use Authorization. There has been positive results with the patients who have received this infusion treatment and we are hopeful this will continue to prove beneficial in reducing the severity of COVID-19 symptoms. In addition, we are hopeful this monoclonal antibody infusion will aid in preventing more hospitalizations.
WE COME TO YOU FOR YOUR MIAMI MONOCLONAL ANTIBODY INFUSION TREATMENT!
If you’re interested in a monoclonal antibody treatment, and are uncomfortable coming to our Miami Shores clinic do not fret! Our nurses will come to you will all proper PPE attire to protect themselves and you and your family. We will administer the Covid-19 Monoclonal antibody treatment in the comfort of your home safely and comfortably. Delivery fees do apply for the at home service. Please call us to book now!
WHO CAN QUALIFY FOR COVID-19 MONOCLONAL ANTIBODY TREATMENTS
How is “high risk” defined? High risk patients must meet at least one of the following criteria:
- Body mass index (BMI) > 35
- Have Chronic kidney disease
- If you have diabetes mellitus
- Those with immunosuppressive disease
- If you are currently receiving immunosuppressive treatment
- Age of at least 65 years old
- If you are at least 55 years of age AND have a cardiovascular disease, hypertension or chronic obstructive pulmonary disease
Monoclonal antibodies are laboratory-produced molecules. They can act as substitute antibodies that may restore, enhance or mimic the immune system’s attack on cells.
HOW MUCH DOES THE REGENERON COVID-19 MONOCLONAL ANTIBODIES TREATMENT COST IN MIAMI??
Please call us for pricing options and to see if you qualify for our Monoclonal antibodies treatment by Regencov. Treatment can be administered at our Miami Shores clinic or administered at your home by one of our nurses. Nurses come to your home with all proper PPE so you don’t have to worry about the spread of infection to our staff.
REGENERON COVID-19 MONOCLONOAL ANTIBODIES TREATMENT FAQ
REGENCOV ANTIBODY TREATMENT IN MIAMI
The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for REGEN-COV™ (casirivimab and imdevimab). This authorization is for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients. Pediatric patients include patients 12 years of age and older weighing at least 40 kg. Both ages have to be diagnosed with positive results of direct SARS-CoV-2 viral testing. Lastly, those who are at high risk for progression to severe COVID-19, including hospitalization or death are also approved for the RegenCOV antibody treatment.
WHAT ARE THE LIMITATIONS IF ANY TO THE COVID-19 MONOCLONAL ANTIBODY TREATMENTS?
Limitations of Authorized Use (Treatment) REGEN-COV is not authorized for use in patients:
- who are hospitalized due to COVID-19
- who require oxygen therapy due to COVID-19
- who require an increase in baseline oxygen flow rate due to COVID-19
- in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity Monoclonal antibodies, such as REGEN-COV, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high-flow oxygen or mechanical ventilation
WHAT IS THE DIFFERENCE BETWEEN REGENERON AND REGEN-COV TREATMENTS?
There is none. Regeneron is the company that administers the Regen-Cov Monoclonal antibody treatments for Covid-19
DOES MEDI-STATION URGENT CARE OFFER COVID-19 TESTING IN MIAMI?
WHAT TO KNOW ABOUT COVID-19 TESTING IN MIAMI
If you have tested positive for COVID-19 whether you had symptoms or not at the time of testing please visit https://FloridahealthCOVID19.gov to obtain isolation guidance and return to work guidelines.
IF YOU HAVE TESTED NEGATIVE FOR COVID-19
With a negative test, Miami residents should consider these results in combination with your symptom and exposure history. Keep in mind you are not qualified for a Covid-19 Monoclonal antibody treatment with a negative Covid-19 test.
WHAT TYPE OF COVID-19 TESTING IS AVAILABLE AT YOUR MIAMI SHORES CLINIC?
Medi-Station provides convenient and safe Covid -19 Testing for individuals, families and businesses in the Miami area. For groups we can even do at your location!
Anyone can be tested upon request. Monday through Sunday, 7 days a week.
Hours of Operation:
Mon-Fri 9:00am – 8:00pm
Saturday 10:00am – 5:00pm
Sunday 10:00am – 5:00pm
Active Infection: We test for active infections via a PCR Nasal swab . Our private laboratory has results available usually in 24 hours.
Remote Exposure: We utilize two tests to see if you have been exposed in the past:
- IGg / IGm – results 15 mins
- Rapid covid antigen tests – also 15 minute results
- PCR tests – results within 24 hours
How Do I Get My Covid-19 Results?
Our State of the art CLIA Approved Labs provide a written lab report usually in 24 hours. Antibody tests performed in office will be given while in office.